⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2019TheranosticsOpen Access

SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy

Yingjie Zhang Liming Nie Keqian Xu Yang Fu Juchang Zhong Kongzhen Gu Lingling Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

: The results uncover SIRT6 as a new potential biomarker for colon cancer, and its unappreciated mechanism about transcription and expression via Akt/FoxO3a pathway.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2019) studied this question.

synapsesocial.com/papers/6a08f5f82142fc3a3073a989 https://doi.org/10.7150/thno.29724

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Piezoelectric hydrogels empowering closed-loop smart medicine: from self-powered sensing to autonomous therapyTheranostics · Sun,
2The biomechanics of the gut in mechanical regulation of microbial ecology and translational opportunitiesTheranostics · Sun,
3Tannic acid-serum albumin (TASA) complex maintains cell viability and protects from oxidative damage during hypothermic preservationTheranostics · Sun,
4A conserved glycolytic malignant subcluster drives invasive progression through a PPIA-BSG metabolic-immune interaction in early lung adenocarcinomaTheranostics · Sun,
5Engineered extracellular vesicle therapies for regulating gut immunity: advances and challengesTheranostics · Sun,

More from Theranostics

A CSF ctDNA-based molecular panel for minimally invasive diagnosis of primary CNS lymphomaSun,
Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked PolyubiquitinationWed,
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagyWed,
DCTN2 inhibited cellular senescence through targeting TRIM21 mediated MST2 ubiquitination and activation in hepatocellular carcinomaThu,
NOD1 is a key mediator of atrial myopathy in heart failureThu,